SENORES PHARMACEUTICALS
Back to Balance Sheet
|
SENORES PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹-19 Cr | ₹-15 Cr | ₹2.10 Cr | ₹-0.45 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of SENORES PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹-19 Cr |
| Mar2024 | ₹-15 Cr |
| Mar2023 | ₹2.10 Cr |
| Mar2022 | ₹-0.45 Cr |
How is Deferred Tax Assets / Liabilities of SENORES PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-19 Cr | Negative | |
| Mar2024 | ₹-15 Cr | Negative | |
| Mar2023 | ₹2.10 Cr | Positive | |
| Mar2022 | ₹-0.45 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of SENORES PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SENORES PHARMACEUTICALS | ₹6,275.4 Cr | 3.1% | -0.2% | 110.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.5% | 2.5% | 14.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 7.4% | 22.2% | 26.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 3.1% | 4.3% | 38.5% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -1.6% | -1.4% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 1.5% | -15.2% | -9.1% | Stock Analytics | |
SENORES PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SENORES PHARMACEUTICALS | 3.1% |
-0.2% |
110.7% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses